Welcome to CADQAS UK & Europe

CADQAS CIC is an independent, not-for-profit community interest company set up to support the introduction & adoption of high-quality new cancer diagnostic & predictive tests (biomarkers).


CADQAS CIC supports and provides training in the interpretation of on-slide biomarkers either on site or elsewhere in UK or Europe, using our mobile pathology classroom.

Training courses offered to date include biomarker interpretation in Non-Small Cell Lung Cancer (e.g. ALK, SP263), Urothelial Carcinoma (SP142) and Triple Negative Breast Cancer (SP142). We also offer more general training courses on interpretation of diagnostic markers in lung and breast.

To be notified when future training courses are available please fill in the form below.

Please contact us if you would like to discuss the development of future training courses.

Proficiency Testing

CADQAS CIC currently offers digital interpretive proficiency testing in the Middle East. We are in the process of expanding our portfolio and we are developing a number of pilot schemes for participants in other parts of the world. These will involve circulations of a small number of digital slides approximately twice a year for each biomarker.

Please use the form below to register your interest in hearing about more about our assessments.

Be notified about future CADQAS Proficiency Testing & and training sessions:

* indicates required

Please select all the ways you would like to hear from CADQAS:

You can unsubscribe at any time by clicking the link in the footer of our emails. For more information see our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Contact us

For information on research services, training and other queries, please get in touch for more information